朗天药业（湖北）有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
23
NMPA:23
Drug Approvals
Somatostatin for Injection
- Product Name
- 注射用生长抑素
- Approval Number
- 国药准字H20244215
- Approval Date
- Jun 28, 2024
NMPA
Salbutamol Sulfate Inhalation Solution
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20234467
- Approval Date
- Nov 7, 2023
NMPA
Thymalfasin for Injection
- Product Name
- 注射用胸腺法新
- Approval Number
- 国药准字H20183329
- Approval Date
- Mar 9, 2023
NMPA
Esomeprazole Sodium for Injection
- Product Name
- 注射用艾司奥美拉唑钠
- Approval Number
- 国药准字H20183081
- Approval Date
- Jan 31, 2023
NMPA
Esomeprazole Sodium for Injection
- Product Name
- 注射用艾司奥美拉唑钠
- Approval Number
- 国药准字H20183080
- Approval Date
- Jan 31, 2023
NMPA
Methionine and Vitamin B1 for Injection
- Product Name
- 注射用甲硫氨酸维B1
- Approval Number
- 国药准字H20080221
- Approval Date
- Jul 1, 2022
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found